The combined results from phytochemical analyses, antioxidant assays, in vitro experiments, network pharmacology predictions, and molecular docking strongly suggest that MBP, particularly its active constituent naringenin, effectively suppresses melanoma proliferation and migration through the modulation of the JAK-STAT signaling pathway. Here, SOAT1 is linked to melanoma.